Federal Court of Appeal affirms prohibition order against Apotex regarding abiraterone
By EsqSocial Corporation 06/04/21
As previously reported, in the final decision released under the pre-amended Patented Medicines (Notice of Compliance) Regulations (Regulations), the Federal Court granted a prohibition order relating to Canadian Patent No. 2,661,422 (422 patent), Apotex, and its abiraterone acetate product (Janssen’s ZYTIGA). Apotex appealed....
By: Smart & Biggar